News

Business Insider6mon
TransCode Therapeutics, Inc. Announces $8 Million Private Placement
BOSTON, Nov. 27, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), the RNA Oncology Company™ committed to more effectively t... Menu icon A vertical stack of three evenly ...
Business Insider1y
TransCode Therapeutics Reports 2023 Results; Provides Business Update
BOSTON, April 03, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today ...
Yahoo Finance1y
TransCode Therapeutics and Debiopharm Announce Collaboration to Develop Targeted Nucleic Acid Therapeutics for Cancer - Yahoo Finance
Project to test combination of TransCode’s proprietary TTX delivery platform and Debiopharm’s drug delivery technologiesBOSTON, Jan. 29, 2024 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc ...